Health-related quality of life in people with predementia Alzheimer’s disease, mild cognitive impairment or dementia measured with preference-based instruments: a systematic literature review

Abstract

Background Obtaining reliable estimates of the health-related quality of life (HR-QoL) of people with predementia Alzheimer’s disease [AD] (preclinical or prodromal AD), mild cognitive impairment (MCI) and dementia is essential for economic evaluations of related health interventions. Aims To provide an overview of which quality of life instruments are being used to assess HR-QoL in people with predementia AD, MCI or dementia; and, to summarise their reported HR-QoL levels at each stage of the disease and by type of respondent. Methods We systematically searched for and reviewed eligible studies published between January 1990 and the end of April 2017 which reported HR-QoL for people with predementia AD, MCI or dementia. We only included instruments which are preference-based, allowing index scores/utility values to be attached to each health state they describe based on preferences obtained from population surveys. Summary results were presented by respondent type (self or proxy), type of instrument, geographical location and, where possible, stage of disease. Health state utility values derived using the EuroQoL 5-Dimensions (EQ-5D) were meta-analysed by pooling reported results across all studies by disease severity (MCI, mild, mild to moderate, moderate, severe dementia, not specified) and by respondent (person with dementia, carer, general public, not specified), using a fixed-effects approach. Results We identified 61 studies which reported HR-QoL for people with MCI or dementia using preference-based instruments, of which 48 used the EQ-5D. Thirty-six studies reported HR-QoL for mild and/or moderate disease severities, and 12 studies reported utility values for MCI. We found systematic differences between self-rated and proxy-rated HR-QoL, with proxy-rated utility valued being significantly lower in more severe disease states. Conclusions A substantial literature now exists quantifying the impact of dementia on HR-QoL using preference-based measures, giving researchers and modellers a firmer basis on which to select appropriate utility values when estimating the effectiveness and cost-effectiveness of interventions in this area. Further research is required on HR-QoL of people with preclinical and prodromal AD and MCI, possible differences by type of dementia, the effects of comorbidities, study setting and the informal caregiver’s own HR-QoL, including any effect of that on their proxy-ratings.

Predicted Lifetime Health Outcomes for Aducanumab in Patients with Early Alzheimer’s Disease

“…Patient utilities for individuals with MCI due to AD and AD dementia were selected from a systematic literature review and meta-analysis by Landeiro et al [ 45 ], which included self-reported and proxy-reported utilities for individuals at each AD severity health state (Table S3 in the electronic supplementary material). In the model, the proxy-reported European Quality of Life-5 Dimensions (EQ-5D) estimates were used because patients in later stages of AD dementia may provide less reliable self-rated assessments [ 46 ].…”

Multi-mechanical waves against Alzheimer’s disease pathology: a systematic review

“…In line with previous systematic reviews in AD [ 32 , 33 ], the quality assessment of the reviewed clinical studies was performed using the Effective Public Health Practice Project (EPHPP) Quality Assessment Tool, and classified according to their global rating as having low (no “Weak” ratings), moderate (one “Weak” rating) or high (two or more “Weak” ratings) risk of bias [ 34 ]. For animal studies, the Stroke Therapy Academic Industry Roundtable (STAIR) preclinical recommendations were used [ 35 ].…”

Prevalence of cognitive impairment in Chinese older inpatients and its relationship with 1-year adverse health outcomes: a multi-center cohort study

“…It is a general scale, which does not distinguish between MCI patients and participants with normal cognitive function. It is short, easy to use and has good feasibility, acceptability and reliability [ 24 ]. In a cross-sectional study of an urban general population in China [ 25 ], it showed moderate level of test–retest reliability.…”